[headerBranded]

Non hai trovato l'analisi che cercavi?

Esegui una ricerca nel nostro database

TAT:

[xyz-ips snippet="TAT"]

Tipo di Campione:

[xyz-ips snippet="Campioni"]

Metodica:

[xyz-ips snippet="Metodologia"]

Prezzo Listino:

€ [xyz-ips snippet="prezzolistino"]

Analisi presente in:

[xyz-ips snippet="branche"]

[visualizzaBrandAnalisi]

OncoNext™ Risk – Oncoscreening Complete

OncoNext ™ Risk OncoScreening Complete is a diagnostic test, developed by GENOMA Group, which allows you to perform a multiple genetic analysis to assess the predisposition to hereditary cancers, including: Breast Cancer, Ovarian / Uterus Cancer, Colorectal Cancer, Stomach Cancer, Pancreatic Cancer, Prostate Cancer, Skin Cancer (Melanoma), Brain Cancer, Kidney Cancer and Pheochromocytoma / Paraganglioma.
OncoNext ™ Risk OncoScreening Complete allows patients to know, through the analysis of their DNA, if they are predisposed to the development of a particular type of cancer. The test, therefore, allows to identify people at risk of developing a specific neoplasia.

[brandLinkReferral]

Geni/Polimorfismi:

[xyz-ips snippet="Geni"]

[sliderBranded]

Richiesta Informazioni

Se desideri ricevere informazioni compila i campi a fianco, ti contatteremo al più presto.

info@laboratoriogenoma.eu

+39 06164161500

[wpforms id="10871" title="false"]